Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause

OBJECTIVE: Sleep disturbances are common among women in midlife; prevalence increases among perimenopausal/postmenopausal women with vasomotor symptoms. Paroxetine 7.5 mg is the only nonhormonal treatment that has been approved in the United States for moderate to severe vasomotor symptoms associate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Menopause
Hauptverfasser: Pinkerton, JoAnn V., Joffe, Hadine, Kazempour, Kazem, Mekonnen, Hana, Bhaskar, Sailaja, Lippman, Joel
Format: Artigo
Sprache:Inglês
Veröffentlicht: Lippincott-Raven Publishers 2015
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274337/
https://ncbi.nlm.nih.gov/pubmed/25137243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000000311
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge